Skip to content
Review Open access

Inflammatory mechanisms of pancreatic β-cell dysfunction and therapeutic strategies in type 2 diabetes mellitus: a narrative review

Sep 2026 · Journal of Diabetes and Metabolic Disorders · Vol 25 · 0 citations · 120 references
Medicine

TL;DR

Evidence from human and experimental studies supports interactions among glucotoxicity, lipotoxicity, oxidative and endoplasmic reticulum stress, mitochondrial dysfunction, islet macrophage activation, cytokine signalling, and β-cell dysfunction, and evidence for the causal importance of individual inflammasome, regulated cell-death, extracellular-vesicle, and gene-regulatory pathways remains predominantly preclinical.

Read PDF

Similar papers

Review Open access Sep 2026

Immunometabolism in Obesity-Associated Type 2 Diabetes: Molecular Mechanisms and Emerging Therapeutic Targets

A narrative review synthesises mechanisms and examines how metformin, glucagon-like peptide-1 receptor agonists, sodium–glucose cotransporter 2 inhibitors and inflammasome-directed agents intersect with them in obesity-associated T2D.

C. Acierno, Massimiliano Cavallo, D. D'Ardes et al. · 0 citations
Review Open access Aug 2026

The integrated stress response in pancreatic β-cell failure in diabetes: from molecular mechanisms to precision therapeutics

Diabetes mellitus is a global metabolic disorder characterized by progressive pancreatic β-cell failure, which leads to inadequate insulin secretion, often in combination with insulin resistance, and ultimately disrupts glucose homeostasis. The Integrated Stress Response (ISR), a crucial signaling network that enables...

Yi-Jun Huang, Yu Zeng, Xinying Zhong et al. · 0 citations
Review Open access Sep 2026

Type 2 diabetes mellitus: emerging mechanistic insights, evolving therapeutic strategies, and future perspectives

Type 2 diabetes mellitus (T2DM) is a complex and progressive metabolic disorder driven by interactions among genetic susceptibility, environmental influences, and metabolic dysfunction. Although insulin resistance and pancreatic β-cell dysfunction remain central to disease pathogenesis, emerging evidence highlights the...

Himanshu, Suryakant Verma, Sonam Yadav et al. · 0 citations
Review Open access Sep 2026

Immune Mechanisms and Translational Therapeutic Challenges in Type 1 Diabetes.

AIMS Type 1 diabetes mellitus (T1DM) is an autoimmune disease driven by genetic susceptibility and triggered by environmental cues. This review aims to systematically elaborate the full pathogenic cascade of T1DM involving the crosstalk among genetics, environment, immunity and pancreatic target cells, and summarize cu...

Hai-Jun Xu, Meng-Hua Ma, Zhe Jia et al. · 0 citations
Review Open access 2021

Insulin physiology and metabolic control: current concepts and perspectives

Type 2 diabetes (T2D) results from progressive failure of multiple interconnected metabolic nodes. This review synthesizes evidence that β-cell dedifferentiation, mediated by loss of PDX-1, MAFA, and NKX6.1 and by epigenetic silencing of their promoters, may represent a leading mechanism of β-cell dysfunction, potentia...

Cozar-Castellano Irene, L. Astrid, Perdomo German et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.